As of Apr 20
| +0.0014 / +0.41%|
The 2 analysts offering 12-month price forecasts for Synthetic Biologics Inc have a median target of 3.25, with a high estimate of 3.50 and a low estimate of 3.00. The median estimate represents a +851.41% increase from the last price of 0.34.
The current consensus among 1 polled investment analysts is to Buy stock in Synthetic Biologics Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.